Dimethyl Fumarate Capsule, Delayed Release
NDC Package 43547-024-14
Package Information
Dimethyl Fumarate capsules is dimethyl fumarate is used to treat multiple sclerosis (MS). This formulation utilizes a capsule, delayed release delivery system. Marketed by Solco Healthcare Us, Llc, this product is identified by NDC 43547-024 and is authorized under FDA application ANDA210414.
Identification & Billing
- RxCUI: 1373483 - dimethyl fumarate 120 MG Delayed Release Oral Capsule
- RxCUI: 1373491 - dimethyl fumarate 240 MG Delayed Release Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43547 - Solco Healthcare Us, Llc
- 43547-024 - Dimethyl Fumarate
- 43547-024-14 - 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC
- 43547-024 - Dimethyl Fumarate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43547-024-14 identifies a specific commercial package of 14 capsule, delayed release in 1 bottle, plastic of Dimethyl Fumarate, a human prescription drug labeled by Solco Healthcare Us, Llc. This capsule, delayed release is formulated for oral use and contains dimethyl fumarate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Solco Healthcare Us, Llc on October 18, 2022. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Dimethyl fumarate is used to treat multiple sclerosis (MS). It is not a cure for MS. It helps decrease the number of episodes of worsening MS.
How is this Solco Healthcare Us, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43547002414. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 14 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.